Detalhe da pesquisa
1.
Proposal for reference values for the developmental effects of valproate based on human data using a benchmark dose approach.
Regul Toxicol Pharmacol
; 139: 105367, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36828241
2.
Evaluating the impact of chemotherapy-induced nausea and vomiting on daily functioning in patients receiving dexamethasone-sparing antiemetic regimens with NEPA (netupitant/palonosetron) in the cisplatin setting: results from a randomized phase 3 study.
BMC Cancer
; 22(1): 915, 2022 Aug 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-35999527
3.
Efficacy of the dexamethasone-sparing triplet regimen for preventing cisplatin-induced emesis: a combined analysis.
Future Oncol
; 18(30): 3389-3397, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-36017782
4.
Efficacy and safety of netupitant/palonosetron combination (NEPA) in preventing nausea and vomiting in non-Hodgkin's lymphoma patients undergoing to chemomobilization before autologous stem cell transplantation.
Support Care Cancer
; 30(2): 1521-1527, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34533630
5.
Post hoc Analysis of a Randomized, Controlled, Phase 2 Study to Assess Response Rates with Chlormethine/Mechlorethamine Gel in Patients with Stage IA-IIA Mycosis Fungoides.
Dermatology
; 238(2): 347-357, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-34091453
6.
Dexamethasone-Sparing Regimens with Oral Netupitant and Palonosetron for the Prevention of Emesis Caused by High-Dose Cisplatin: A Randomized Noninferiority Study.
Oncologist
; 26(10): e1854-e1861, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34101934
7.
Single-dose netupitant/palonosetron versus 3-day aprepitant for preventing chemotherapy-induced nausea and vomiting: a pooled analysis.
Future Oncol
; 17(23): 3027-3035, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-33878896
8.
Netupitant/palonosetron (NEPA) and dexamethasone for prevention of emesis in breast cancer patients receiving adjuvant anthracycline plus cyclophosphamide: a multi-cycle, phase II study.
BMC Cancer
; 20(1): 232, 2020 Mar 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-32188417
9.
Impact of dexamethasone-sparing regimens on delayed nausea caused by moderately or highly emetogenic chemotherapy: a meta-analysis of randomised evidence.
BMC Cancer
; 19(1): 1268, 2019 Dec 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-31888544
10.
Improved outcome of patients with relapsed/refractory Hodgkin lymphoma with a new fotemustine-based high-dose chemotherapy regimen.
Br J Haematol
; 172(1): 111-21, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26458240
11.
Withdrawal of valproic acid treatment during pregnancy and seizure outcome: Observations from EURAP.
Epilepsia
; 57(8): e173-7, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27319360
12.
Epidemiology and outcome of Clostridium difficile infections in patients hospitalized in Internal Medicine: findings from the nationwide FADOI-PRACTICE study.
BMC Infect Dis
; 16(1): 656, 2016 11 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27825317
13.
Should clinicians always administer dexamethasone beyond 24 h after chemotherapy to control delayed nausea and vomiting caused by moderately emetogenic regimens? Insight from the re-evaluation of two randomized studies.
Support Care Cancer
; 24(3): 1025-34, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26245497
14.
Prulifloxacin vs Levofloxacin for Exacerbation of COPD after Failure of Other Antibiotics.
COPD
; 13(5): 555-60, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27027547
15.
Mobilization of hematopoietic stem cells with lenograstim in healthy donors: efficacy and safety analysis according to donor age.
Biol Blood Marrow Transplant
; 21(5): 881-8, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25636377
16.
Pharmacokinetic study between a bilayer matrix fentalyl patch and a monolayer matrix fentanyl patch: single dose administration in healthy volunteers.
Br J Clin Pharmacol
; 80(1): 110-5, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25612845
17.
Evaluation of an every-other-day palonosetron schedule to control emesis in multiple-day high-dose chemotherapy.
Future Oncol
; 10(16): 2569-78, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24947121
18.
Feasibility and safety of a reduced duration of therapy of colony-stimulating factor in a dose-dense regimen.
Support Care Cancer
; 22(9): 2557-61, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24740178
19.
Risk of Major Congenital Malformations and Exposure to Antiseizure Medication Monotherapy.
JAMA Neurol
; 81(5): 481-489, 2024 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38497990
20.
Effects of iloprost on pain-free walking distance and clinical outcome in patients with severe stage IIb peripheral arterial disease: the FADOI 2bPILOT Study.
Eur J Clin Invest
; 43(11): 1163-70, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-24102344